Matthew McAviney

Matthew McAviney is a Partner on the Healthcare team at New Enterprise Associates (NEA) based in Menlo Park, California. Before joining the firm in 2018, he served as a Principal at F-Prime Capital, where he closed investments in more than 20 private biopharma companies and held over 10 board seats at organizations like Escient Pharma. His earlier career includes roles in healthcare investment banking at JP Morgan, biotech equity research at Robert W. Baird, and life sciences consulting at Oliver Wyman. He holds a Bachelor of Arts in Biological Sciences and a Master of Business Administration from the University of Chicago, alongside a Doctor of Medicine from the University of Illinois. McAviney currently leverages his combined clinical and financial background to focus on seed, early, and growth-stage biopharma investments across the broader healthcare sector.